Live Quote · NASDAQDRMAHealthcare· Biotechnology

Dermata Therapeutics, Inc.

$0.51▼ 4.23%($-0.02)
MKT CAP $2.51MNEXT EARNINGS Mar 31, 2027
50%
Bullish
TickerSpark Score
59/100
▌ Mixed
80
Valuation
40
Profitability
60
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a DRMA research report →

Analyst Price Target
$6.00+1077.6% vs. today

Range $6 – $6

Analyst RatingBuy
1 Buy0 Hold0 Sell

Price Chart

-79.62% · this period
$3.14$1.82$0.51Nov 20May 26Nov 20
52-Week Range0% of range
Low
$0.50
Current
$0.51
High
$4.66